Skip to content

Consider Excising These “Unhealthy” Biotech Stocks From Your Portfolio

When it comes to the seven “unhealthy” biotech stocks that are the focus of today’s article, the author advises the following: “While these aren’t terrible stocks, they’re stocks best exited before a correction hits or their momentum slows further.” For these seven biotech stocks to consider selling “before they sicken your portfolio”, CLICK HERE.